Clinical Trials on Pancreatic Neuroendocrine Tumor G2 in Switzerland
Total 165 results
-
University Hospital, Basel, SwitzerlandSwiss National Science Foundation; Paul Scherrer Institute (PSI)RecruitingNeuroendocrine Neoplasia's (NENs) | Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)Switzerland
-
University Hospital Inselspital, BerneUniversity Hospital, Basel, Switzerland; University of Lausanne Hospitals; University... and other collaboratorsTerminatedGastroenteropancreatic Neuroendocrine TumorsSwitzerland
-
University Hospital, Basel, SwitzerlandUniversity Hospital, Zürich; University Hospital Freiburg; Krebsforschung Schweiz... and other collaboratorsRecruitingThyroid Cancer, Medullary | Neuroendocrine Tumor of the Lung Grade 1 and 2 | Neuroendocrine Tumor of the Thymus Grade 1 and 2 | Neuroendocrine Tumor GEP Grade 1-3Switzerland
-
Novartis PharmaceuticalsTerminatedPancreatic Neuroendocrine Tumors (pNET)United Kingdom, Spain, Netherlands, Italy, Russian Federation, France, Switzerland, United States
-
IpsenCompletedGastroenteropancreatic Neuroendocrine TumorsSwitzerland
-
Novartis PharmaceuticalsCompletedAdvanced Neuroendocrine Tumors of Pancreatic OriginCanada, France, United Kingdom, Taiwan, Belgium, Spain, Netherlands, United States, Italy, Sweden, Switzerland, Thailand, Germany, Greece, Korea, Republic of, Japan, Brazil, Slovakia
-
University Hospital Inselspital, BerneCompletedMerkel Cell Carcinoma | Malignant MelanomaSwitzerland
-
Novartis PharmaceuticalsCompletedMetastatic Melanoma and Merkel Cell CarcinomaGermany, Switzerland
-
University Hospital, Basel, SwitzerlandNot yet recruitingNeuroendocrine TumorsSwitzerland
-
University Hospital Inselspital, BerneCompletedNeuroendocrine Tumors of the AppendixSwitzerland
-
Felix BeuschleinRadboud University Medical Center; University of Zurich; Ludwig-Maximilians -... and other collaboratorsRecruitingPheochromocytoma | ParagangliomaSwitzerland
-
Prof. Dr. Silke GillessenTerminated
-
University of Lausanne HospitalsFond'action contre le cancer; Barletta Foundation; NCCR (National Center of Competence...Suspended
-
University Hospital, Basel, SwitzerlandActive, not recruitingNeuroendocrine TumorsSwitzerland
-
University of ZurichCompleted
-
University Hospital, Basel, SwitzerlandAnaveon AGRecruiting
-
Centre Hospitalier Universitaire VaudoisCompletedOcular MelanomaSwitzerland
-
Cytos Biotechnology AGCompletedMalignant MelanomaSwitzerland
-
John O. PriorTerminated
-
Centre Hospitalier Universitaire VaudoisImmutep S.A.S.Terminated
-
Hoffmann-La RocheCompletedA Pharmacokinetic and Metabolism Study of 14C-labeled RO5185426 on Patients With Metastatic MelanomaMalignant MelanomaSwitzerland
-
University of ZurichCompleted
-
Centre Hospitalier Universitaire VaudoisLudwig Institute for Cancer ResearchCompleted
-
Centre Hospitalier Universitaire VaudoisActive, not recruitingMetastatic MelanomaSwitzerland
-
Centre Hospitalier Universitaire VaudoisLudwig Institute for Cancer ResearchCompleted
-
University Hospital Inselspital, BerneCompleted
-
Markus JoergerRecruiting
-
Cytos Biotechnology AGCompletedMalignant MelanomaSwitzerland
-
Swiss Group for Clinical Cancer ResearchCompletedMelanoma (Skin)Switzerland
-
Prof. Serge LeyvrazCompleted
-
Cytos Biotechnology AGCompletedMalignant MelanomaSwitzerland
-
University Hospital Inselspital, BerneUniversity Hospital, Geneva; University Hospital, Basel, Switzerland; University... and other collaboratorsRecruitingNeuroendocrine Tumors | Carcinoid TumorSwitzerland
-
University of ZurichCompletedMelanoma Stage III or IV | No Prior ChemotherapySwitzerland
-
Centre Hospitalier Universitaire VaudoisActive, not recruitingMetastatic Melanoma Naive to Immune Therapy in Metastatic SettingSwitzerland
-
Centre Hospitalier Universitaire VaudoisCompleted
-
University Hospital, Basel, SwitzerlandCompleted
-
AmgenNo longer availableUnresected Stage IIIB to IVM1c MelanomaSwitzerland
-
University Hospital, Basel, SwitzerlandCompleted
-
University of ZurichCompletedMerkel Cell Carcinoma | Basal Cell Carcinoma | Squamous Cell Carcinoma | Non-melanoma Skin Cancer | Cutaneous LymphomaSwitzerland
-
NovartisCompletedMetastatic MelanomaSwitzerland
-
University Hospital, Basel, SwitzerlandGMP network of BaselCompletedAdvanced MelanomaSwitzerland
-
University Hospital, Basel, SwitzerlandCompleted
-
IpsenCompletedAcromegaly | Neuroendocrine TumoursSwitzerland, Austria, Germany
-
OnxeoCompletedMelanomaAustria, France, Germany, Switzerland
-
IpsenActive, not recruitingNeuroendocrine TumorsAustria, Denmark, Switzerland, Australia, United Kingdom, France
-
Centre Hospitalier Universitaire VaudoisRecruitingMetastasis From Malignant Melanoma of Skin (Diagnosis)Switzerland
-
IpsenTerminatedNeuroendocrine TumorsUnited States, Australia, Austria, Canada, Denmark, France, Switzerland, United Kingdom
-
Philogen S.p.A.Eudax S.r.l.TerminatedMetastatic MelanomaSwitzerland, Italy, Austria, Germany
-
University of ZurichCantonal Hospital of St. Gallen; Triemli Hospital; Kantonsspital Winterthur KSWCompletedAdenocarcinoma | Pancreatic Neoplasms | Circulating Tumor CellsSwitzerland
-
University Hospital, GenevaSuspendedStage IB Skin Melanoma | Stages III Skin Melanoma | Stages II Skin MelanomaSwitzerland